ArticleBMJ public health2025
Prevalence and factors associated with uptake of cervical cancer screening at primary care facilities in Trinidad: a cross-sectional study.
Article in BMJ public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The use of the Papanicolaou (Pap) test for early detection of cervical carcinoma is well-established. This study determined the prevalence and factors associated with cervical cancer screening compared with nonscreening among women accessing primary care health centres in North-Central Trinidad. Methods: A descriptive, cross-sectional study was conducted using a convenience sample of women between the ages of 21 and 65 years attending walk-in primary care clinics during the period February 2018 to July 2018. A total of 435 self-administered questionnaires were completed, which included both de novo and validated tools from previous cervical cancer research. The questionnaire was structured along the Health Belief Model. χ Results: 435 women were approached and 432 participated, yielding a response rate of 99.3%. Most of the participants fell into the 31-40-year age group (27.6%), 27.1% in the 21-30-year age group, 23.2% in the 41-49-year age group and 22.1% in the 50-65-year age group. The prevalence of screening for cervical cancer screening was found to be 63.3%. A significant association (p<0.05) was found between age and self-reported ethnicity with screening for cervical carcinoma. Barriers such as being embarrassed and perceived interference with sexual function were significantly associated with nonscreening (p<0.05). Conclusion: This study revealed a higher than expected prevalence of cervical cancer screening among women attending select primary care facilities in North-Central Trinidad. This rate was well below the 80% target recommended by the Pan American Health Organization and WHO. As such, further work is required to improve perceptions, overcome barriers and strengthen primary healthcare delivery systems to enhance uptake of Pap smear screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.